The use of neurotrophin therapy in the inner ear to augment cochlear implantation outcomes

Anatomical Record

Volumn 295, Issue 11, 2012, Pages 1896-1908

  Budenz, Cameron L ^a   Pfingst, Bryan E ^a   Raphael, Yehoash ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

BDNF; Cochlear implant; Neurotrophin; NT3

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4;

ACOUSTIC NERVE FIBER; ARTICLE; CELL SURVIVAL; COCHLEA PROSTHESIS; DISEASE SEVERITY; DRUG USE; ELECTROSTIMULATION; HEARING IMPAIRMENT; HUMAN; IMPLANTATION; INNER EAR; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE REGENERATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOPHYSIOLOGY; SPIRAL GANGLION;

ANIMALS; COCHLEA; COCHLEAR IMPLANTATION; DEAFNESS; EAR, INNER; HUMANS; NERVE GROWTH FACTORS;

ANIMALIA;

EID: 84867895292     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.22586     Document Type: Article

References (101)

1. Abrashkin KA, Izumikawa M, Miyazawa T, Wang C-H, Crumling MA, Swiderski DL, Beyer LA, Gong T-WL, Raphael Y. 2006. The fate of outer hair cells after acoustic or ototoxic insults. Hear Res 218: 20-29.
2. Adamson CL, Reid MA, Davis RL. 2002. Opposite actions of brain-derived neurotrophic factor and neurotrophin-3 on firing features and ion channel composition of murine spiral ganglion neurons. J Neurosci 22: 1385-1396.
3. Agterberg MJH, Versnel H, de Groot JCMJ, Smoorenburg GF, Albers FWJ, Klis SFL. 2008. Morphological changes in spiral ganglion cells after intracochlear application of brain-derived neurotrophic factor in deafened guinea pigs. Hear Res 244: 25-34.
4. Agterberg MJH, Versnel H, van Dijk LM, de Groot JCMJ, Klis SFL. 2009. Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs. J Assoc Res Otolaryngol 10: 355-367.
5. Altschuler RA, Cho Y, Ylikoski J, Pirvola U, Magal E, Miller JM. 1999. Rescue and regrowth of sensory nerves following deafferentation by neurotrophic factors. Ann N Y Acad Sci 884: 305-311.
6. Bankiewicz KS, Forsayeth J, Eberling JL, Sanchez-Pernaute R, Pivirotto P, Bringas J, Herscovitch P, Carson RE, Eckelman W, Reutter B, Cunningham J. 2006. Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. Mol Ther 14: 564-570.
7. Bermingham NA, Hassan BA, Price SD, Vollrath MA, Ben-Arie N, Eatock RA, Bellen HJ, Lysakowski A, Zoghbi HY. 1999. Math1: an essential gene for the generation of inner ear hair cells. Science 284: 1837-1841.
8. Bichler E, Spoendlin H, Rauchegger H. 1983. Degeneration of cochlear neurons after amikacin intoxication in the rat. Arch Otorhinolaryngol 237: 201-208.
9. Bohne BA, Harding GW. 1992. Neural regeneration in the noise-damaged chinchilla cochlea. The Laryngoscope 102: 693-703.
10. Brown JN, Miller JM, Altschuler RA, Nuttall AL. 1993. Osmotic pump implant for chronic infusion of drugs into the inner ear. Hear Res 70: 167-172.
11. Campbell VA, Crews JE, Moriarty DG, Zack MM, Blackman DK. 1999. Surveillance for sensory impairment, activity limitation, and health-related quality of life among older adults--United States, 1993-1997. MMWR CDC Surveill Summ 48: 131-156.
12. Chikar JA, Colesa DJ, Swiderski DL, Di Polo A, Raphael Y, Pfingst BE. 2008. Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons. Hear Res 245: 24-34.
13. Chikar JA, Hendricks JL, Richardson-Burns SM, Raphael Y, Pfingst BE, Martin DC. 2012. The use of a dual PEDOT and RGD-functionalized alginate hydrogel coating to provide sustained drug delivery and improved cochlear implant function. Biomaterials 33: 1982-1990.
14. Cohen LT, Lenarz T, Battmer R-D, Bender von Saebelkampf C, Busby PA, Cowan RSC. 2005. A psychophysical forward masking comparison of longitudinal spread of neural excitation in the Contour and straight Nucleus electrode arrays. Int J Audiol 44: 559-566.
15. Cohen LT, Saunders E, Knight MR, Cowan RSC. 2006. Psychophysical measures in patients fitted with Contour and straight Nucleus electrode arrays. Hear Res 212: 160-175.
16. Davis RL, Liu Q. 2011. Complex primary afferents: What the distribution of electrophysiologically-relevant phenotypes within the spiral ganglion tells us about peripheral neural coding. Hear Res 276: 34-43.
17. Dorman MF, Loizou PC, Fitzke J, Tu Z. 1998. The recognition of sentences in noise by normal-hearing listeners using simulations of cochlear-implant signal processors with 6-20 channels. J Acoust Soc Am 104: 3583-3585.
18. Ernfors P, Duan ML, ElShamy WM, Canlon B. 1996. Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat Med 2: 463-467.
19. Ernfors P, Van De Water T, Loring J, Jaenisch R. 1995. Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron 14: 1153-1164.
20. Fariñas I, Jones KR, Backus C, Wang XY, Reichardt LF. 1994. Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 369: 658-661.
21. Fariñas I, Jones KR, Tessarollo L, Vigers AJ, Huang E, Kirstein M, de Caprona DC, Coppola V, Backus C, Reichardt LF, Fritzsch B. 2001. Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression. J Neurosci 21: 6170-6180.
22. Fayad JN, Linthicum FH. 2006. Multichannel cochlear implants: relation of histopathology to performance. The Laryngoscope 116: 1310-1320.
23. Fitzgerald MB, Shapiro WH, McDonald PD, Neuburger HS, Ashburn-Reed S, Immerman S, Jethanamest D, Roland JT, Svirsky MA. 2007. The effect of perimodiolar placement on speech perception and frequency discrimination by cochlear implant users. Acta Otolaryngol 127: 378-383.
24. Friesen LM, Shannon RV, Baskent D, Wang X. 2001. Speech recognition in noise as a function of the number of spectral channels: comparison of acoustic hearing and cochlear implants. J Acoust Soc Am 110: 1150-1163.
25. Frijns JH, Briaire JJ, Grote JJ. 2001. The importance of human cochlear anatomy for the results of modiolus-hugging multichannel cochlear implants. Otol Neurotol 22: 340-349.
26. Fritzsch B, Fariñas I, Reichardt LF. 1997. Lack of neurotrophin 3 causes losses of both classes of spiral ganglion neurons in the cochlea in a region-specific fashion. J Neurosci 17: 6213-6225.
27. Fritzsch B, Jahan I, Pan N, Kersigo J, Duncan J, Kopecky B. 2011. Dissecting the molecular basis of organ of Corti development: Where are we now? Hear Res 276: 16-26.
28. Gillespie LN, Clark GM, Bartlett PF, Marzella PL. 2003. BDNF-induced survival of auditory neurons in vivo: Cessation of treatment leads to accelerated loss of survival effects. J Neurosci Res 71: 785-790.
29. Glueckert R, Bitsche M, Miller JM, Zhu Y, Prieskorn DM, Altschuler RA, Schrott-Fischer A. 2008. Deafferentation-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor. J Comp Neurol 507: 1602-1621.
30. Havenith S, Versnel H, Agterberg MJH, de Groot JCMJ, Sedee R-J, Grolman W, Klis SFL. 2011. Spiral ganglion cell survival after round window membrane application of brain-derived neurotrophic factor using gelfoam as carrier. Hear Res 272: 168-177.
31. Hawkins JE. 1973. Comparative otopathology: aging, noise, and ototoxic drugs. Adv Otorhinolaryngol 20: 125-141.
32. Hinojosa R, Lindsay JR. 1980. Profound deafness. Associated sensory and neural degeneration. Arch Otolaryngol 106: 193-209.
33. Huang EJ, Reichardt LF. 2001. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24: 677-736.
34. Izumikawa M, Batts SA, Miyazawa T, Swiderski DL, Raphael Y. 2008. Response of the flat cochlear epithelium to forced expression of Atoh1. Hear Res 240: 52-56.
35. Izumikawa M, Minoda R, Kawamoto K, Abrashkin KA, Swiderski DL, Dolan DF, Brough DE, Raphael Y. 2005. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med 11: 271-276.
36. Johnsson LG, Hawkins JE. 1972. Strial atrophy in clinical and experimental deafness. The Laryngoscope 82: 1105-1125.
37. Johnsson LG, Hawkins JE. 1976. Degeneration patterns in human ears exposed to noise. Ann Otol Rhinol Laryngol 85: 725-739.
38. Kang SY, Colesa DJ, Swiderski DL, Su GL, Raphael Y, Pfingst BE. 2010. Effects of hearing preservation on psychophysical responses to cochlear implant stimulation. J Assoc Res Otolaryngol 11: 245-265.
39. Kanzaki S, Stöver T, Kawamoto K, Prieskorn DM, Altschuler RA, Miller JM, Raphael Y. 2002. Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J Comp Neurol 454: 350-360.
40. Kawamoto K, Ishimoto S-I, Minoda R, Brough DE, Raphael Y. 2003. Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci 23: 4395-4400.
41. Kawano A, Seldon HL, Clark GM, Ramsden RT, Raine CH. 1998. Intracochlear factors contributing to psychophysical percepts following cochlear implantation. Acta Otolaryngol 118: 313-326.
42. Kerr A, Schuknecht HF. 1968. The spiral ganglion in profound deafness. Acta Otolaryngol 65: 586-598.
43. Khan AM, Handzel O, Burgess BJ, Damian D, Eddington DK, Nadol JB. 2005. Is word recognition correlated with the number of surviving spiral ganglion cells and electrode insertion depth in human subjects with cochlear implants? The Laryngoscope 115: 672-677.
44. Kim YH, Raphael Y. 2007. Cell division and maintenance of epithelial integrity in the deafened auditory epithelium. Cell Cycle 6: 612-619.
45. Kong Y-Y, Cruz R, Jones JA, Zeng F-G. 2004. Music Perception with Temporal Cues in Acoustic and Electric Hearing. Ear Hear 25: 173-185.
46. Lalwani A, Walsh B, Reilly P, Carvalho G, Zolotukhin S, Muzyczka N, Mhatre A. 1998. Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus. Gene Ther 5: 277-281.
47. Lalwani AK, Mhatre AN. 2003. Cochlear gene therapy. Ear Hear 24: 342-348.
48. Lawner BE, Harding GW, Bohne BA. 1997. Time course of nerve-fiber regeneration in the noise-damaged mammalian cochlea. Int J Dev Neurosci 15: 601-617.
49. Lefebvre PP, Malgrange B, Staecker H, Moghadass M, Van de Water TR, Moonen G. 1994. Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. Neuroreport 5: 865-868.
50. Linthicum FH, Fayad JN. 2009. Spiral ganglion cell loss is unrelated to segmental cochlear sensory system degeneration in humans. Otol Neurotol 30: 418-422.
51. Lu B, Pang PT, Woo NH. 2005. The yin and yang of neurotrophin action. Nat Rev Neurosci 6: 603-614.
52. Merchan-Perez A, Liberman MC. 1996. Ultrastructural differences among afferent synapses on cochlear hair cells: correlations with spontaneous discharge rate. J Comp Neurol 371: 208-221.
53. Merchant SN, Adams JC, Nadol JB. 2005. Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss. Otol Neurotol 26: 151-160.
54. Miller JM, Chi DH, O'Keeffe LJ, Kruszka P, Raphael Y, Altschuler RA. 1997. Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci 15: 631-643.
55. Miller JM, Le Prell CG, Prieskorn DM, Wys NL, Altschuler RA. 2007. Delayed neurotrophin treatment following deafness rescues spiral ganglion cells from death and promotes regrowth of auditory nerve peripheral processes: effects of brain-derived neurotrophic factor and fibroblast growth factor. J Neurosci Res 85: 1959-1969.
56. Morton NE. 1991. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci 630: 16-31.
57. Mou K, Hunsberger CL, Cleary JM, Davis RL. 1997. Synergistic effects of BDNF and NT-3 on postnatal spiral ganglion neurons. J Comp Neurol 386: 529-539.
58. Nadol JB. 1997. Patterns of neural degeneration in the human cochlea and auditory nerve: implications for cochlear implantation. Otolaryngol Head Neck Surg 117: 220-228.
59. Nadol JB, Shiao JY, Burgess BJ, Ketten DR, Eddington DK, Gantz BJ, Kos I, Montandon P, Coker NJ, Roland JT, Shallop JK. 2001. Histopathology of cochlear implants in humans. Ann Otol Rhinol Laryngol 110: 883-891.
60. Nadol JB, Young YS, Glynn RJ. 1989. Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol 98: 411-416.
61. Nakaizumi T, Kawamoto K, Minoda R, Raphael Y. 2004. Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol Neurootol 9: 135-143.
62. Nayagam BA, Muniak MA, Ryugo DK. 2011. The spiral ganglion: connecting the peripheral and central auditory systems. Hear Res 278: 2-20.
63. Noushi F, Richardson RT, Hardman J, Clark G, O'leary S. 2005. Delivery of neurotrophin-3 to the cochlea using alginate beads. Otol Neurotol 26: 528-533.
64. Pfingst BE, Bowling SA, Colesa DJ, Garadat SN, Raphael Y, Shibata SB, Strahl SB, Su GL, Zhou N. 2011. Cochlear infrastructure for electrical hearing. Hear Res 281: 65-73.
65. Pfingst BE, Sutton D. 1983. Relation of cochlear implant function to histopathology in monkeys. Ann N Y Acad Sci 405: 224-239.
66. Pirvola U, Ylikoski J, Palgi J, Lehtonen E, Arumäe U, Saarma M. 1992. Brain-derived neurotrophic factor and neurotrophin 3 mRNAs in the peripheral target fields of developing inner ear ganglia. Proc Natl Acad Sci USA 89: 9915-9919.
67. Raphael Y, Altschuler RA. 2003. Structure and innervation of the cochlea. Brain Res Bull 60: 397-422.
68. Raphael Y, Frisancho JC, Roessler BJ. 1996. Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo. Neurosci Lett 207: 137-141.
69. Rejali D, Lee VA, Abrashkin KA, Humayun N, Swiderski DL, Raphael Y. 2007. Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear Res 228: 180-187.
70. Richardson RT, Noushi F, O'leary S. 2006. Inner ear therapy for neural preservation. Audiol Neurootol 11: 343-356.
71. Richardson RT, O'leary S, Wise A, Hardman J, Clark G. 2005. A single dose of neurotrophin-3 to the cochlea surrounds spiral ganglion neurons and provides trophic support. Hear Res 204: 37-47.
72. Richardson RT, Wise A, O'leary S, Hardman J, Casley D, Clark G. 2004. Tracing neurotrophin-3 diffusion and uptake in the guinea pig cochlea. Hear Res 198: 25-35.
73. Ruan RS, Leong SK, Mark I, Yeoh KH. 1999. Effects of BDNF and NT-3 on hair cell survival in guinea pig cochlea damaged by kanamycin treatment. Neuroreport 10: 2067-2071.
74. Santi PA, Mancini P. 1998. Cochlear Anatomy and Central Auditory Pathways. Otolaryngology Head and Neck Surgery, Ed C Cummings 3rd Ed: 2803-2830.
75. Santi PA, Ruggero MA, Nelson DA, Turner CW. 1982. Kanamycin and bumetanide ototoxicity: anatomical, physiological and behavioral correlates. Hear Res 7: 261-279.
76. Shepherd RK, Coco A, Epp SB, Crook JM. 2005. Chronic depolarization enhances the trophic effects of brain-derived neurotrophic factor in rescuing auditory neurons following a sensorineural hearing loss. J Comp Neurol 486: 145-158.
77. Shepherd RK, Javel E. 1997. Electrical stimulation of the auditory nerve. I. Correlation of physiological responses with cochlear status. Hear Res 108: 112-144.
78. Shibata SB, Cortez SR, Beyer LA, Wiler JA, Di Polo A, Pfingst BE, Raphael Y. 2010. Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleae. Exp Neurol 223: 464-472.
79. Shinohara T, Bredberg G, Ulfendahl M, Pyykkö I, Olivius NP, Kaksonen R, Lindström B, Altschuler R, Miller JM. 2002. Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci USA 99: 1657-1660.
80. Shoji F, Miller AL, Mitchell A, Yamasoba T, Altschuler RA, Miller JM. 2000. Differential protective effects of neurotrophins in the attenuation of noise-induced hair cell loss. Hear Res 146: 134-142.
81. Spoendlin H. 1971a. Degeneration behaviour of the cochlear nerve. Arch Klin Exp Ohren Nasen Kehlkopfheilkd 200: 275-291.
82. Spoendlin H. 1971b. Primary structural changes in the organ of Corti after acoustic overstimulation. Acta Otolaryngol 71: 166-176.
83. Spoendlin H, Suter R. 1976. Regeneration in the VIII nerve. Acta Otolaryngol 81: 228-236.
84. Sprinzl GM, Riechelmann H. 2010. Current trends in treating hearing loss in elderly people: a review of the technology and treatment options - a mini-review. Gerontology 56: 351-358.
85. Staecker H, Gabaizadeh R, Federoff H, Van de Water TR. 1998. Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol Head Neck Surg 119: 7-13.
86. Staecker H, Galinovic-Schwartz V, Liu W, Lefebvre P, Kopke R, Malgrange B, Moonen G, Van de Water TR. 1996a. The role of the neurotrophins in maturation and maintenance of postnatal auditory innervation. Am J Otol 17: 486-492.
87. Staecker H, Kopke R, Malgrange B, Lefebvre P, Van de Water TR. 1996b. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 7: 889-894.
88. Strominger RN, Bohne BA, Harding GW. 1995. Regenerated nerve fibers in the noise-damaged chinchilla cochlea are not efferent. Hear Res 92: 52-62.
89. Sugawara M, Murtie JC, Stankovic KM, Liberman MC, Corfas G. 2007. Dynamic patterns of neurotrophin 3 expression in the postnatal mouse inner ear. J Comp Neurol 501: 30-37.
90. Terayama Y, Kaneko K, Tanaka K, Kawamoto K. 1979. Ultrastructural changes of the nerve elements following disruption of the organ of Corti. II. Nerve elements outside the organ of Corti. Acta Otolaryngol 88: 27-36.
91. Terayama Y, Kaneko Y, Kawamoto K, Sakai N. 1977. Ultrastructural changes of the nerve elements following disruption of the organ of Corti. I. Nerve elements in the organ of Corti. Acta Otolaryngol 83: 291-302.
92. Teufert KB, Linthicum FH, Connell SS. 2006. The effect of organ of corti loss on ganglion cell survival in humans. Otol Neurotol 27: 1146-1151.
93. Weiss MA, Frisancho JC, Roessler BJ, Raphael Y. 1997. Viral-mediated gene transfer in the cochlea. Int J Dev Neurosci 15: 577-583.
94. Wise AK, Hume CR, Flynn BO, Jeelall YS, Suhr CL, Sgro BE, O'Leary SJ, Shepherd RK, Richardson RT. 2010. Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea. Mol Ther 18: 1111-1122.
95. Wise AK, Richardson R, Hardman J, Clark G, O'leary S. 2005. Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3. J Comp Neurol 487: 147-165.
96. Wright CG. 1976. Neural damage in the guinea pig cochlea after noise exposure. A light microscopic study. Acta Otolaryngol 82: 82-94.
97. Xu L, Tsai Y, Pfingst BE. 2002. Features of stimulation affecting tonal-speech perception: implications for cochlear prostheses. J Acoust Soc Am 112: 247-258.
98. Yamagata T, Miller JM, Ulfendahl M, Olivius NP, Altschuler RA, Pyykkö I, Bredberg G. 2004. Delayed neurotrophic treatment preserves nerve survival and electrophysiological responsiveness in neomycin-deafened guinea pigs. J Neurosci Res 78: 75-86.
99. Ylikoski J, Pirvola U, Moshnyakov M, Palgi J, Arumäe U, Saarma M. 1993. Expression patterns of neurotrophin and their receptor mRNAs in the rat inner ear. Hear Res 65: 69-78.
100. Zappia JJ, Altschuler RA. 1989. Evaluation of the effect of ototopical neomycin on spiral ganglion cell density in the guinea pig. Hear Res 40: 29-37.
101. Zhou Z, Liu Q, Davis RL. 2005. Complex regulation of spiral ganglion neuron firing patterns by neurotrophin-3. J Neurosci 25: 7558-7566.